Federated Hermes’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $164M | Sell |
3,849,802
-904,557
| -19% | -$40.4M | 0.24% | 107 |
|
|
2026
Q1 | $229M | Buy |
4,754,359
+1,112,052
| +31% | +$51.8M | 0.37% | 59 |
|
|
2025
Q4 | $177M | Buy |
3,642,307
+607,053
| +20% | +$30.1M | 0.29% | 89 |
|
|
2025
Q3 | $143M | Sell |
3,035,254
-852,375
| -22% | -$41.1M | 0.25% | 100 |
|
|
2025
Q2 | $188M | Sell |
3,887,629
-59,954
| -2% | -$3.06M | 0.35% | 68 |
|
|
2025
Q1 | $219M | Buy |
3,947,583
+1,456,269
| +58% | +$78.8M | 0.47% | 41 |
|
|
2024
Q4 | $120M | Sell |
2,491,314
-834,724
| -25% | -$42.4M | 0.26% | 94 |
|
|
2024
Q3 | $192M | Buy |
3,326,038
+111,897
| +3% | +$6.04M | 0.42% | 47 |
|
|
2024
Q2 | $156M | Buy |
3,214,141
+673,172
| +26% | +$32.5M | 0.37% | 58 |
|
|
2024
Q1 | $123M | Buy |
2,540,969
+823,649
| +48% | +$40.2M | 0.28% | 84 |
|
|
2023
Q4 | $85.4M | Sell |
1,717,320
-755,840
| -31% | -$37M | 0.21% | 113 |
|
|
2023
Q3 | $133M | Sell |
2,473,160
-95,408
| -4% | -$5.09M | 0.35% | 58 |
|
|
2023
Q2 | $138M | Buy |
2,568,568
+466,819
| +22% | +$25.1M | 0.34% | 56 |
|
|
2023
Q1 | $114M | Buy |
2,101,749
+1,856,263
| +756% | +$90.3M | 0.29% | 72 |
|
|
2022
Q4 | $11.9M | Sell |
245,486
-101,412
| -29% | -$4.45M | 0.03% | 500 |
|
|
2022
Q3 | $13.2M | Sell |
346,898
-53,101
| -13% | -$2.37M | 0.04% | 467 |
|
|
2022
Q2 | $20M | Buy |
399,999
+100,988
| +34% | +$5.36M | 0.05% | 390 |
|
|
2022
Q1 | $15.4M | Buy |
299,011
+82,936
| +38% | +$4.28M | 0.03% | 505 |
|
|
2021
Q4 | $10.8M | Sell |
216,075
-14,500
| -6% | -$717K | 0.02% | 624 |
|
|
2021
Q3 | $11.1M | Sell |
230,575
-9,792
| -4% | -$498K | 0.02% | 618 |
|
|
2021
Q2 | $12.7M | Buy |
240,367
+18,742
| +8% | +$978K | 0.02% | 589 |
|
|
2021
Q1 | $11M | Buy |
221,625
+515
| +0.2% | +$24.7K | 0.02% | 641 |
|
|
2020
Q4 | $10.7M | Sell |
221,110
-10,448
| -5% | -$515K | 0.02% | 624 |
|
|
2020
Q3 | $11.6M | Buy |
231,558
+10,806
| +5% | +$556K | 0.03% | 537 |
|
|
2020
Q2 | $11.3M | Sell |
220,752
-97,403
| -31% | -$4.73M | 0.03% | 515 |
|
|
2020
Q1 | $13.9M | Buy |
318,155
+5,269
| +2% | +$252K | 0.04% | 411 |
|
|
2019
Q4 | $15.7M | Buy |
312,886
+1,646
| +0.5% | +$77.1K | 0.04% | 479 |
|
|
2019
Q3 | $14.4M | Sell |
311,240
-8,388
| -3% | -$362K | 0.04% | 450 |
|
|
2019
Q2 | $13.8M | Buy |
319,628
+1,229
| +0.4% | +$52.3K | 0.03% | 471 |
|
|
2019
Q1 | $14.1M | Sell |
318,399
-193,467
| -38% | -$8.29M | 0.03% | 440 |
|
|
2018
Q4 | $22.2M | Buy |
511,866
+194,102
| +61% | +$8.56M | 0.06% | 302 |
|
|
2018
Q3 | $14.2M | Sell |
317,764
-1,786,196
| -85% | -$76.3M | 0.03% | 452 |
|
|
2018
Q2 | $84.2M | Sell |
2,103,960
-148,576
| -7% | -$5.85M | 0.25% | 88 |
|
|
2018
Q1 | $90.3M | Sell |
2,252,536
-182,844
| -8% | -$7.61M | 0.26% | 77 |
|
|
2017
Q4 | $105M | Sell |
2,435,380
-929,123
| -28% | -$42.8M | 0.3% | 66 |
|
|
2017
Q3 | $168M | Sell |
3,364,503
-1,132,864
| -25% | -$54.8M | 0.48% | 40 |
|
|
2017
Q2 | $215M | Sell |
4,497,367
-626,321
| -12% | -$29.9M | 0.62% | 28 |
|
|
2017
Q1 | $232M | Buy |
5,123,688
+289,790
| +6% | +$12.3M | 0.66% | 23 |
|
|
2016
Q4 | $195M | Sell |
4,833,898
-1,098,426
| -19% | -$43.3M | 0.59% | 26 |
|
|
2016
Q3 | $227M | Buy |
5,932,324
+2,072,086
| +54% | +$83.1M | 0.65% | 28 |
|
|
2016
Q2 | $162M | Buy |
3,860,238
+1,307,272
| +51% | +$53.6M | 0.47% | 39 |
|
|
2016
Q1 | $103M | Buy |
2,552,966
+1,312,956
| +106% | +$52.7M | 0.32% | 65 |
|
|
2015
Q4 | $52.9M | Sell |
1,240,010
-193,291
| -13% | -$8.89M | 0.17% | 120 |
|
|
2015
Q3 | $68M | Buy |
1,433,301
+44,714
| +3% | +$2.28M | 0.22% | 89 |
|
|
2015
Q2 | $68.8M | Buy |
1,388,587
+114,561
| +9% | +$5.81M | 0.21% | 96 |
|
|
2015
Q1 | $63M | Buy |
1,274,026
+1,115,471
| +704% | +$53.3M | 0.19% | 105 |
|
|
2014
Q4 | $7.23M | Buy |
158,555
+44,328
| +39% | +$2.15M | 0.02% | 524 |
|
|
2014
Q3 | $6.45M | Sell |
114,227
-120,213
| -51% | -$6.46M | 0.02% | 560 |
|
|
2014
Q2 | $12.5M | Sell |
234,440
-337,428
| -59% | -$17.9M | 0.04% | 400 |
|
|
2014
Q1 | $29.9M | Buy |
571,868
+407,785
| +249% | +$20.6M | 0.1% | 201 |
|
|
2013
Q4 | $8.8M | Buy |
164,083
+76,404
| +87% | +$3.94M | 0.03% | 487 |
|
|
2013
Q3 | $4.44M | Sell |
87,679
-7,508
| -8% | -$382K | 0.02% | 631 |
|
|
2013
Q2 | $4.9M | Buy |
+95,187
| New | +$5.07M | 0.02% | 586 |
|
Other funds holding SNY
MIP
BIP
Federated Hermes's SNY Position: Q2 2026 in Review
Federated Hermes reduced its Sanofi (SNY) stake by 19% in Q2 2026, selling an estimated $40.4M and leaving 3,849,802 shares worth $164M. The position accounts for 0.24% of the portfolio, ranked #107.
Federated Hermes first reported a position in SNY in Q2 2013 and has held it in 53 quarters since. The position peaked at $232M in Q1 2017. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Federated Hermes held 3,849,802 shares of Sanofi worth $164M as of Q2 2026.
- Federated Hermes sold 904,557 Sanofi shares in Q2 2026, an estimated $40.4M.
- Sanofi made up 0.24% of Federated Hermes's portfolio in Q2 2026, its #107 holding.
- Federated Hermes first reported a position in Sanofi in Q2 2013 and has held it in 53 quarters since.
- Federated Hermes's Sanofi position peaked at $232M in Q1 2017.
- 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.